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Abstract
Background: Streptococcus suis is a zoonotic pathogen that causes infections in young piglets. S. suis is a
heterogeneous species. Thirty-three different capsular serotypes have been described, that differ in virulence
between as well as within serotypes.
Results: In this study, the correlation between gene content, serotype, phenotype and virulence among 55 S. suis
strains was studied using Comparative Genome Hybridization (CGH). Clustering of CGH data divided S. suis isolates
into two clusters, A and B. Cluster A isolates could be discriminated from cluster B isolates based on the protein
expression of extracellular factor (EF). Cluster A contained serotype 1 and 2 isolates that were correlated with
virulence. Cluster B mainly contained serotype 7 and 9 isolates. Genetic similarity was observed between serotype
7 and serotype 2 isolates that do not express muramidase released protein (MRP) and EF (MRP-EF-), suggesting
these isolates originated from a common founder. Profiles of 25 putative virulence-associated genes of S. suis were
determined among the 55 isolates. Presence of all 25 genes was shown for cluster A isolates, whereas cluster B
isolates lacked one or more putative virulence genes. Divergence of S. suis isolates was further studied based on
the presence of 39 regions of difference. Conservation of genes was evaluated by the definition of a core genome
that contained 78% of all ORFs in P1/7.
Conclusions: In conclusion, we show that CGH is a valuable method to study distribution of genes or gene
clusters among isolates in detail, yielding information on genetic similarity, and virulence traits of S. suis isolates.
Background
Streptococcus suis forms a problem in the swine indus-
try. Clinically healthy sows carry S. suis in their nasal
cavities and on their tonsils, and transmit the bacteria to
their piglets [1], that develop a variety of infections, such
as septicaemia, meningitis, polyarthritis, and endocardi-
tis, and often do not survive [2]. S. suis occasionally
causes meningitis, arthritis or endocarditis in humans.
However, recently several large human outbreaks of S.
suis have been described in China [3,4], and Thailand
[5], whilst S. suis meningitis has become endemic in
Vietnam [6,7], suggesting that isolates that are more
virulent to humans have emerged.
The S. suis population is very heterogeneous as differ-
ent serotypes, phenotypes, and genotypes are found. To
date 33 capsular serotypes have been described for S.
suis [2,8] of which serotypes 1, 2, 7, 9, and 14 are most
frequently isolated from diseased pigs in Europe [9]. In
Northern America, besides these serotypes, serotypes 3
and 8 are frequently isolated from diseased animals
[10,11]. On European farms, it was shown that up to
81% of healthy animals carried one or more serotypes
simultaneously and different genotypes of the same ser-
otype could be isolated at one timepoint from the same
animal [12]. Different phenotypes of serotype 2 were
described that differ in their virulence; strains can be
differentiated by protein expression of virulence markers
muramidase released protein (MRP), extracellular factor
(EF) and suilysin (SLY) [13,14]. Besides variation in pro-
tein expression observed among S. suis strains, large
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heterogeneity also exists in gene composition [10,15-17].
Recently, the genome sequence of S. suis serotype 2
strain P1/7 became available [7] enabling whole genome
typing techniques for S. suis. In the present study, we
performed oligonucleotide-based comparative genome
hybridization (CGH) using the genome sequence of
strain P1/7 to evaluate gene conservation and diversity
among S. suis strains. Fifty-five well characterized S. suis
strains of various serotypes were analyzed in this CGH
study. Results from CGH were clustered, and correlated
with MLST data, serotyping results, and virulence of
strains. We showed that groups of S. suis isolates can be
identified by their own unique profile of putative viru-
lence genes and regions of difference. Besides, a core
genome for S. suis was defined.
Methods
Bacterial strains and growth conditions
Bacterial isolates are described in Table 1. S. suis strains
were grown on Columbia agar blood base plates (Oxoid
Ltd., London, United Kingdom) containing 6% (vol/vol)
horse blood. Cultures were grown in Todd-Hewitt broth
(Oxoid). Escherichia coli was grown in Luria Broth
(Oxoid) and plated on Luria Broth Agar (Oxoid). S. suis
isolates used in this study were serotyped using the
slide-agglutination test [18] before they were used in the
study (Table 1). Expression of three virulence markers,
MRP, EF, and SLY [19,20] was confirmed for all isolates
by Western blot analysis [9] using monoclonal antibo-
dies against MRP, EF [21], or SLY [22] (Table 1).
Experimental infection in pigs
All animal experiments were approved by the ethical
committee of the Central Veterinary Institute of Wagen-
ingen UR in accordance with the Dutch law on animal
experiments.
In this study virulence of S. suis isolates was strictly
defined by the outcome of experimental infections. To
study virulence of S. suis serotype 1 and 9 isolates, three
successive experiments were performed in pigs. Previous
to infection all piglets were tested negative for S. suis
carriership. In all experiments pigs were allotted to
three or four groups each consisting of four or five pigs
(Table 2). In the first two experiments seventeen caesar-
ian-derived germfree piglets were housed in stainless
steel incubators as described before [21]. Each piglet
was infected at the age of 5 days with Bordetella bronch-
iseptica (3 × 107 CFU, intranasally) to predispose ani-
mals for subsequent S. suis infection. Two days later
animals were infected intranasally with exponentially
growing S. suis strains (1 × 106 CFU aerosol).
In the third experiment, specific pathogen free (SPF)
piglets with the age of 6 weeks were infected intranasally
with S. suis serotype 9 isolates (1 × 109 CFU) without
prior predisposition to B. bronchiseptica. Piglets were
kept in sternal position and forced to inhale an aerosol
produced by an airbrush (Badger, Franklin Park, USA)
after anaesthesia with 50% O2/50% N2O/3% halothane.
In all experiments, piglets were followed clinically with
special regard to signs of meningitis and arthritis. Swabs
for bacteriological examination were taken daily from
the oropharynx and faeces. Pigs were killed either mori-
bund or 18 days post infection at the end of the obser-
vation period by intravenous injection of
pentobarbiturate followed by exsanguination and
necropsy. Tissue specimens from the central nervous
system (CNS), serosae, and joints were examined bacter-
iologically and histologically [21,23].
Multi Locus Sequence Typing (MLST)
MLST was performed as described by King et al. [24].
Alternative primers for mutS were used as described
previously by Rehm et al. [25]. Chromosomal DNA was
isolated from stationary growing bacteria as described
previously [26]. PCR reactions were performed using
Taq PCR Core kit (QIAgen, Hilden, Germany) accord-
ing to the manufacturer’s instructions, using 5 μl of
diluted (1:100) chromosomal DNA as template, contain-
ing at least 350 ng of DNA. PCR products were visually
inspected on 1% agarose gels containing ethidium bro-
mide, and subsequently purified and sequenced by
Macrogen (Macrogen, Seoul, Korea). Sequence data
were analyzed using Lasergene software (DNAstar,
Madison, USA). MLST alleles and resulting STs were
assigned using the database on http://ssuis.mlst.net/.
New alleles and STs were assigned by the curator of the
database. Analysis of ST complexes was performed with
eBURST http://www.mlst.net[27].
S. suis oligoarray
A S. suis oligoarray (8 × 15 K) containing in situ synthe-
sized 60-mers was produced by Agilent Technologies
(Santa Clara, USA), according to a custom probe design
based on the genome sequence of S. suis P1/7 [7]. A
total of 7651 unique 60-mers having a theoretical melt-
ing temperature of approximately 81°C and representing
1960 ORFs were selected as described by Saulnier et al.
[28]. Genes were represented by 4 (91%), 3 (4%), 2 (2%),
or 1 probe (3%). A total of 25 putative genes were not
represented on the array because no unique probe satis-
fying the selection criteria could be selected.
Comparative genome hybridization (CGH)
Chromosomal DNA (50 μg) was sheared in 1 ml shearing
buffer (TE/10% glycerol), using Nebulizers (Invitrogen,
Carlsbad, USA) under 1.7 bar air pressure for 3 minutes to
yield fragments between 500 and 1500 bp. DNA was etha-
nol precipitated, taken up in water and 10 μg of DNA was
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Table 1 Characteristics of bacterial strains used in this study
Strain Serotype Virulence* ST MRP# EF# SLY# Clinical source Reference/source
6388 1 HV 1 S + + Organs Laboratory collection [32]
6112 1 HV 1 S + + Organs Laboratory collection [32]
NCTC10273R1 1 V 13 - - + Unknown Laboratory collection [32]
C160 1 ND 1 + + + Brain/septicemia Laboratory collection [9]
C187 1 ND 132 + + + Tonsil/septicemia Laboratory collection [9]
OV585 1 ND 13 - - + Unknown Veterinary Practice Diessen, The Netherlands
12 2 AV 19 - - + Tonsil Laboratory collection [21]
16 2 AV 19 - - +/- Tonsil Laboratory collection [21]
25 2 AV 20 - - + Human Laboratory collection [21]
T15 2 AV 19 - - + Tonsil Laboratory collection [23]
89-1591 2 ND 25 - - - Unknown Groupe de Recherché sur les Maladies Infectieuses du Porc,
Québec, Canada, [56]
3995 2 ND 1 + * - Unknown Laboratory collection [16]
3988 2 ND 1 + * - Unknown Laboratory collection
17 2 WV 8 + * + Tonsil Laboratory collection
S735R2 2 WV 1 + * + Unknown Laboratory collection CVI
1890 2 ND 133 + * + Unknown Laboratory collection
3 2 V 1 + + + CNS Laboratory collection [21]
10 2 V 1 + + + Tonsil Laboratory collection [21]
22 2 V 1 + + + Human Laboratory collection [21]
D282 2 V 1 + + + CNS Laboratory collection [21]
7696 2 ND 1 + + + Joint Groupe de Recherceh sur les Maladies Infectieuses du Porc,
Québec, Canada
P1/7 2 V 1 + + + Unknown Laboratory collection CVI
BM190 2 ND 1 + * + Human sepsis,
meningitis
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
BM191 2 ND 1 + * + Human meningitis Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
BM334 2 ND 1 - + + Human meningitis Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
BM407 2 ND 1 - * + Human meningitis Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
FX59 2 ND 1 - + + tonsil Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
FX125 2 ND 28 + - - tonsil Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
95-8242 2 ND 1 + + + Unknown Groupe de Recherceh sur les Maladies Infectieuses du Porc,
Québec, Canada
89-999 2 ND 25 - - - Unknown Groupe de Recherceh sur les Maladies Infectieuses du Porc,
Québec, Canada, [56]
R75/S2 2 ND 1 + + + Unknown Groupe de Recherceh sur les Maladies Infectieuses du Porc,
Québec, Canada, [56]
98HAH12 2 ND 7 + + + Human TSLS [41]Hua Dong Research Institute for Medicine of Nanjing
Command, Nanjing, China [41]
05ZYH33 2 ND 7 + + + Human TSLS [41]Hua Dong Research Institute for Medicine of Nanjing
Command, Nanjing, China [41]
OV233 2 ND 1 + + + Unknown Veterinary Practice Diessen, The Netherlands
OV349 2 ND 1 + + + Unknown Veterinary Practice Diessen, The Netherlands
OV625 2 ND 1 + + + Unknown Veterinary Practice Diessen, The Netherlands
OV209 4 ND 17 S - - Unknown Veterinary Practice Diessen, The Netherlands
7711 7 ND 29 - - - CNS Laboratory collection [9]
7917 7 ND 29 - - CNS Laboratory collection [9]
8039 7 ND 135 - - - CNS Laboratory collection [9]
C126 7 ND 1 - - - Joint Laboratory collection [9]
15009 7 ND 89 - - - Unknown Laboratory collection [9]
A496/98 7 ND 29 - - - Lung, pneumonia Stiftung Tierärtzliche Hochschule Hannover, Hannover, Germany
[25]
Sw123/B2452 7 ND 29 - - - Lung, pneumonia Stiftung Tierärtzliche Hochschule Hannover, Hannover, Germany
[25]
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column purified using Illustra Cyscribe GFX purification
kit (GE Healthcare, Uppsala, Sweden) according to
instructions of the manufacturer. Differential DNA pre-
sence was determined by two-colour fluorescent hybridi-
zations of the corresponding genomic DNAs on the 8 ×
15 k S. suis oligo array. Genomic DNA of each strain was
cohybridized once with the reference strain P1/7, that was
always labeled with Cy3. The test strain was consequently
labeled with Cy5. Labeling of DNA (2,5 μg) was done
using the Bioprime Array CGH Genomic Labeling System
(Invitrogen) with slight modifications as described by
Molenaar et al., 2005 [29]. Labeling efficiency was mea-
sured using the Nanodrop (ThermoScientific, Wilmington,
USA). Constant amounts of label (25 pmol each) were
hybridized to the oligoarray in hybridization buffer of the
In situ hybridization kit Plus (Agilent Technologies) fol-
lowing instructions of the manufacturer. During hybridiza-
tion, slides were incubated for 17 h at 65°C under rotation.
Slides were washed for 10 min in 6 × SSC/0.05% Triton-
X102 at room temperature, followed by 5 min in 0.1 ×
SSC/0.05% Triton-X102 at 4°C. Slides were dried using
pressured air and scanned in a GenePix 4200AL scanner
(Molecular Devices, Sunnyvale, USA). Scans were analyzed
using GenePix software (Molecular Devices). Local back-
ground values were subtracted from the intensity of each
spot. Data were normalized using S-Lowess [30] at the
webtool accessible from http://bioinformatics.biol.rug.nl/
websoftware/s-lowess. Normalized data were imported
into Acuity software (Molecular Devices) for further analy-
sis. Cut-off values for presence/absence of genes were
empirically determined by comparing microarray results
to classic hybridization results using about 100 radioac-
tively labeled probes on spotted chromosomal DNA (data
not shown). It was determined that a log ratio above -1.5
indicated the gene was present and very homologous to
the gene in P1/7, whereas a log ratio above -4.5 indicated
that the gene was present, but variation in nucleotide
composition existed among isolates. A ratio between -1.5
and -3 indicated slight variation, whereas a ratio between
-3 and -4.5 indicated large variation. A gene was desig-
nated “absent” from a genome when all probes for that
gene had a normalized log ratio below -4.5.
Dendrograms
CGH data was clustered using Acuity software to deter-
mine similarity of isolates tested in the CGH. Hierarchi-
cal clustering of isolates was done by clustering arrays
based on ranked correlation coefficients (Spearman’s
rho), where linkage was determined using the average
neighbours method. P-values were calculated by multi-
scale bootstrap resampling (n = 10000) with the R pack-
age pvclust using the average agglomerative method and
by the absolute correlative distance measure. The pre-
sence of putative virulence genes among isolates, as well
as the presence of regions of difference among isolates,
was visualized in dendrograms using BioNumerics
(Applied Maths, Houston, USA) to study similarity
among isolates. These data were analyzed using the Pear-
son product-moment correlation coefficient. Cluster ana-
lysis was done with the unweighted pair group method
using arithmetic averages (UPGMA) with a 1% optimiza-
tion for position tolerance.
Microarray data
All microarray data have been submitted MIAME com-
plied to ArrayExpress under submission numbers
Table 1 Characteristics of bacterial strains used in this study (Continued)
8074R7 7 ND 25 - - Unknown Laboratory collection CVI
7997 9 AV 16 * - + Organs Laboratory collection [9]
8067 9 AV 136 - - + Unknown Laboratory collection [9]
8017 9 AV 136 - - + CNS Laboratory collection [9]
7709 9 ND 16 * - + Bacteraemia Laboratory collection [9]
C132 9 ND 16 * - + Brain/septicemia Laboratory collection [9]
5973 9 AV 137 * - - CNS Laboratory collection [9]
22083R9 9 ND 82 * - - Unknown Laboratory collection CVI
7998 9 ND 16 + - + Joint Laboratory collection [9]
8186 9 ND 138 * - - Tonsil Laboratory collection [9]
OV640 UT ND 139 * - - Unknown Veterinary Practice Diessen, The Netherlands
2840 PA ND 134 - * + Unknown Laboratory collection
Escherichia
coli TG1
NA NA NA NA NA NA NA Laboratory collection
Rx reference strain of serotype x; UT untypable; PA, poly-agglutination; NA, not applicable; HV, highly virulent; V, virulent; WV, weakly virulent; AV, avirulent; ND,
not determined; MRP, muramidase released protein; EF, extracellular factor; SLY, suilysin; +, protein expressed; -, protein not expressed; *, higher MW protein
expressed; s, smaller MW protein expressed; +/-, protein weakly expressed; CNS, central nervous system; TSLS, toxic shock-like syndrome
* virulence as determined in an experimental infection in pigs
# phenotype, protein expression
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E-MEXP-2531/E-MEXP-2533 http://www.ebi.ac.uk/
microarray-as/ae/.
Results
Clustering of isolates as determined by CGH
CGH was used to study genomic diversity among S. suis
isolates. S. suis isolates from different serotypes, isolated
from different hosts, from different clinical sources, and
from different geographical locations were included in
the study (Table 1). The dendrogram depicting the
CGH data (Figure 1) shows that isolates were divided
into 2 clusters, A and B, whereas the negative control E.
coli strain was assigned to cluster C. This indicates that
there are extensive genetic differences between S. suis
isolates belonging to clusters A and B. Statistical analysis
showed that subclustering of isolates in cluster B was
highly significant (indicated in Figure 1), whereas sub-
clustering of isolates in cluster A was less significant.
This is probably due to high similarity among cluster A
isolates. One statistical outlier was identified, isolate
6388 clustered with E. coli (p = 0.6) in a separate cluster
due to low microarray signals. This was only detected
after multiple bootstrap resampling.
Cluster A exclusively contained serotype 1 and 2 iso-
lates, except for one (isolate 2840), indicating that these
serotypes are genetically very similar. Isolate 2840 was
identified to be poly-agglutinable in a slide agglutination
test, although CGH data showed this isolate contains cps
genes of serotype 2, suggesting the isolate belongs to ser-
otype 2 but does not express (enough) capsule genes suf-
ficiently to be detected in slide agglutination. All isolates
in cluster A expressed either EF protein or the larger
form EF* protein [16], whereas none of the isolates clus-
tered in group B expressed either of these proteins.
MLST analysis showed that with the exception of sero-
type 2 isolate 1890, all isolates in cluster A belonged to
clonal complex 1 (CC1) within which most isolates were
found to represent sequence type 1 (ST1) whereas others
represented single locus variants of ST1. Six subclusters
(A1 - A6) were distinguished in cluster A. Cluster A1
contained MRP+EF+ serotype 2 isolates from different
geographical locations (Canada, Netherlands and China)
that were isolated from humans and pigs, indicating the
global spreading of these isolates. Cluster A2 exclusively
contained serotype 2 isolates from Vietnam either
obtained from human patients or from pigs [6], suggest-
ing these Vietnamese isolates are highly similar to each
other. Discrimination of isolates of the subclusters A1 -
A6 was based on sequence diversity between genes,
rather than on differences in gene content.
Table 2 Virulence of Streptococcus suis serotype 1 and 9 strains determined in pigs
S. suis
strain
Sero-
type
Dose No. of
pigs
Mortality
(%)
Mean time until
death (days)
Specific
Clinical
Signs1
Non-
Specific
Clinical
Signs2
Path.
CNS
Bact.
CNS
Path.
serosae
Bact.
serosae
Path.
joints
Bact.
joints
6388 1 106
CFU$
5CD 100 2 17 37 4 4 4 4 2 4
6112 1 106
CFU$
4CD 100 2 7 36 3 4 1 4 0 4
NCTC10273R1 1 106
CFU$
4CD 100 9.8 6 21 1 2 1 2 4 4
3 2 106
CFU$
4CD 50 7 4 67 0 0 4 3 0 0
3 2 106
CFU$
4CD 50 7.5 25 87 3 3 3 1 2 3
5973 9 106
CFU$
5CD 0 NA 0 0 0 0 2 1 0 0
22083R9 9 106
CFU$
4CD 0 NA 0 0 0 0 0 0 0 1
22083R9 9 109
CFU
4SPF 0 NA 13 0 1 0 0 0 0 1
7997 9 109
CFU
4SPF 25 4 1 2 1 1 0 1 1 2
8067 9 109
CFU
4SPF 0 NA 10 1 0 0 1 0 1 0
28017 9 109
CFU
4SPF 25 1 1 0 1 1 2 0 1 2
$ Animals were predisposed with a B. bronchiseptica infection 2 days before infection with S. suis; CD caesarean-derived germfree piglets; SPF specific pathogen
free piglets; 1 mean number of observations of nervous signs and lameness in one or more joints/total number of observations × 100%; 2 mean number of
observations of inappetence and depression/total number of observations × 100%; Path. Pathology: number of pigs with pathological abnormalities; Bact.
Bacteriology: Number of piglets from which S. suis is reisolated; NA, animals survived until the end of the experiment; CNS Central nervous system.
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Figure 1 Dendrogram of normalized CGH results. S. suis strains are listed in the first column, serotype and phenotype (muramidase released
protein (MRP) and extracellular factor (EF) expression) in the second column. MLST sequence type (ST) and clonal complex (CC) are listed in the
last column. Red color indicates probes that are present in more copies than in P1/7, whereas green color indicates probes that are present in
P1/7, and absent in the test strain. Asterisks indicate statistically significant knots. Solid boxed isolates were shown to be virulent or weakly
virulent in experimental infections; dotted boxed isolates were shown to be avirulent or very weakly virulent in experimental infections; striped -
dotted boxed isolates were isolates from human patients. humanindicates an isolate that was shown to be avirulent in experimental infection, but
was isolated from a human patient.
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In contrast to cluster A, cluster B contained a more
divergent, heterogeneous group of isolates. Cluster B
contained all serotype 7 and 9 isolates included in this
study as well as a number of less virulent serotype 1
and serotype 2 isolates that neither express MRP nor
EF. Within cluster B five subclusters were distinguished
(B1 - B5). Subclusters B1 and B2 contained all serotype
7 isolates, as well as a number of MRP-EF- serotype 2
isolates [21]. The high degree of similarity observed
between MRP-EF- serotype 2 and serotype 7 isolates
could suggest that the MRP-EF- serotype 2 isolates origi-
nated from serotype 7 isolates by an exchange of capsu-
lar genes. This idea is supported by MLST data which
showed that most isolates within the clusters B1 and B2
share the same clonal complex (respectively 16 and 29)
as well as by AFLP-data in which these isolates also
clustered together (data not shown). Cluster B3 was a
very heterogeneous group of isolates that seemed to
contain isolates that were clustered based on lack of
genetic similarity to each other and to other strains.
Surprisingly, the reference strain of serotype 9 (22083R9)
was assigned to cluster B3 as well, at large distance
from other serotype 9 isolates in cluster B5. This clearly
indicates that the reference strain does not represent the
European serotype 9 isolates from the field used in this
study. This was confirmed by MLST data, since this
reference strain was assigned to ST82, an independent
ST, outside a lineage. Cluster B4 contained two serotype
1 isolates among which the reference strain of serotype
1 (NCTC10273R1), indicating extensive sequence differ-
ences between serotype 1 strains in cluster B4 and sero-
type 1 strains in cluster A. In contrast to the serotype 1
isolates present in cluster A, both isolates in cluster B4
were negative for expression of MRP and EF and
belonged to CC13, whereas all serotype 1 isolates in
cluster A belonged to CC1. Therefore, the reference
strain for serotype 1 at best represents part of the sero-
type 1 population. Cluster B5 contained serotype 9 iso-
lates belonging to CC16 as well as a serotype 2 isolate
from a human patient and a serotype 4 isolate both
belonging to CC147.
Virulence of S. suis isolates of serotype 1 and 9
To be able to study the correlation of gene content of
isolates with virulence, we determined the virulence of
serotype 1 and 9 isolates used in this study in experi-
mental infections in pigs in comparison to the virulence
of serotype 2 strain 3 [21]. The reference strains of sero-
type 1 and 9 were included in this experimental infec-
tion, as well as 2 - 3 field isolates of both serotypes.
Table 2 shows that although serotype 1 reference strain
NCTC10273R1 showed less clinical signs than serotype 2
strain 3, mortality of serotype 1 reference strain was
100% whereas strain 2 showed only 50% mortality. Four
piglets infected with this serotype 1 strain showed
pathological abnormalities in joints. Based on morbidity,
mortality and pathological abnormalities in > 50% of
piglets, isolate NCTC10273R1 is considered virulent, like
strain 3. Serotype 1 isolates 6112 and 6388 also showed
a mortality rate of 100%. The mean number of days
until death of these animals was 2 days, whereas for pig-
lets infected with the serotype 1 reference strain this
was 9.8 days. Animals infected with strain 3 showed
50% mortality and a mean number of days until death
of more than 7 days post-infection. Isolates 6112 and
6388 induced pathological abnormalities in CNS in 4
out of 5 piglets and 3 out of 5 piglets, respectively.
Based on these observations, these serotype 1 isolates
are considered more virulent than strain 3 and are
therefore considered highly virulent. Serotype 9 isolates
did not show any clinical symptoms after an intranasal
infection with 106 CFU (Table 2), whereas strain 3
showed 50% mortality and a mean number of days until
death of 7.5. Even an infection dose of 109 CFU of sero-
type 9 only induced mild clinical signs, and sparse
pathological findings. This led to the conclusion that the
serotype 9 isolates tested in our experimental infection
model should be considered avirulent, although they can
induce mild clinical symptoms at a higher dose.
Virulence of isolates as determined in experimental
infections in pigs was depicted in the dendrogram of
CGH data (Figure 1). Except for the virulent reference
strain of serotype 1 that was assigned to cluster B4, all
avirulent isolates were assigned to cluster B, whereas all
virulent, highly virulent and weakly virulent isolates
were assigned to cluster A. MLST data confirmed these
findings, since all isolates in cluster A, except for isolate
1890, belonged to MLST CC1 that was described to
have a strong correlation with invasive diseases, like sep-
ticemia, meningitis and arthritis [24]. All Asian human
isolates that were obtained from meningitis and sepsis
patients were assigned to cluster A as well. The only
Dutch human isolate from a meningitis patient (isolate
25) was shown to be avirulent in an experimental infec-
tion in piglets, and was assigned to cluster B, clearly
indicating that this isolate is genetically distinct from
the highly virulent Asian human isolates [3,4].
Distribution of putative virulence related genes among S.
suis serotype 2 isolates
To correlate virulence of isolates with specific genes, we
next studied the distribution of 25 genes encoding puta-
tive virulence proteins in serotype 2 isolates among iso-
lates. Genes were selected that were described to be
involved in pathogenesis or virulence of S. suis. Cluster-
ing of these results into a dendrogram assigned all iso-
lates to 7 different virulence clusters (V1 - V7) (Figure
2). This clustering was very similar to the clustering
de Greeff et al. BMC Microbiology 2011, 11:161
http://www.biomedcentral.com/1471-2180/11/161
Page 7 of 15
??
?
?????
?????
?????????????
????????????
??????????????
??????????????????
???????????
???????????
???????????
??????????????
???????????
????????????
????????????
?????????
?????????
??????????
????????????
????????????????
??????????????
??????????
?????????
???????????
?????????
?????????
????????
???????????
???????????
???????????
???????????
???????????
??????????????
??????????????
????????????
????????????
????????????
????????????
???????????
???????????
???????????
???????????
????????????
????????????
????????????
?????????????
???????????
????????????
?????????
???????????
???????????
???????????
???????????
???????????
???????????
???????????
????????????
???????????
??????????
??
??????
??
??????
???????
???
???
???
????
??
????
???
????
?
?
?
??
?
??
??
?
?
?
?
??
??
??
??
?
?
?
??
??
??
?
?
?
?
??
??
?
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
?
??
?
?
?
??
??
??
??
?
?
?
??
??
?
??
?
?
?
??
??
??
?
?
?
?
?
??
??
??
?
?
??
??
??
?
?
?
?
??
?
?
??
?
?
?
?
?
??
?
?
??
?
?
?
?
?
??
?
??
?
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
?
?
??
?
?
?
?
??
??
??
?
?
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
?
?
?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
?
?
?
??
?
?
??
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
??
?
??
??
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
?
??
?
?????
????? ??
?
?????
?????
?
?
?
??
?
??
??
?
?
?
?
??
??
??
??
?
?
?
??
??
??
?
?
?
?
??
??
?
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
?
??
?
?
?
??
??
??
??
?
?
?
??
??
?
??
?
?
?
??
??
??
?
?
?
?
?
??
??
??
?
?
??
??
??
?
?
?
?
??
?
?
??
?
?
?
?
?
??
?
?
??
?
?
?
?
?
??
?
??
?
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
?
?
??
?
?
?
?
??
??
??
?
?
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
?
?
?
?
?
?
??
?
?
??
?
?
?
?
?
??
?
??
??
?
?
?
??
?
??
??
?
?
?
?
??
??
??
??
?
?
?
??
??
??
?
?
?
?
??
??
?
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
?
??
?
?
?
??
??
??
??
?
?
?
??
??
?
??
?
?
?
??
??
??
?
?
?
?
?
??
??
??
?
?
??
??
??
?
?
?
?
??
?
?
??
?
?
?
?
?
??
?
?
??
?
?
?
?
?
??
?
??
?
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
?
?
??
?
?
?
?
??
??
??
?
?
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
??
?
?
?
??
??
??
?
?
?
?
?
?
??
?
?
??
?
?
?
?
?
??
?
??
??
Figure 2 Presence/absence of 25 putative virulence genes represented in a dendrogram. Naming (SSU numbering) is derived from the
annotated genome sequence of P1/7 [7]. Presence of 25 described putative virulence factors was studied: muramidase released protein (mrp),
and extracullar factor (epf) [13], suilysin (sly) [20], sortases (srtA, srtBCD, srtF) [34], surface antigen one (sao) [42], hyaluronidase (hylA) [17,43],
opacity factor (ofs) [37], fibronectin binding protein (fbps) [44], arginin deiminase (arcA) [45], glyceraldehyde-3-phosphate dehydrogenase (gapdh)
[46], regulator of virulence (revS) [35,47], enolase (eno) [48], glutamine synthetase (glnA) [49], igA1 protease [36], inosine 5-monophosphate
dehydrogenase (impdh) [50], dipeptidyl peptidase IV (dppIV) [51], ferrous iron transporter (feoB) [52], subtilisin like serine protease (sspA) [53],
amylopullulanase (apuA) [54], ferric uptake regulator (fur), and adhesion competence repressor (adcR) [55]. * hylA is present as pseudogene in P1/
7 and does not have a SSU-number. ‘+’ indicates all probes have a ratio > -1.5 (present); light grey shading indicates one or more probes have a
ratio between -1.5 and -3 (present with slight variation); dark grey shading indicates one or more probes have a ratio between -3 and 4.5
(present with large variation); ‘-’ indicates one or more probes have a ratio < -4.5 (partly or completely absent).
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based on the CGH data, although some isolates were
clustered with isolates that belonged to another CGH
cluster. Isolates assigned to cluster V4 (corresponding to
CGH cluster A) contained all selected putative virulence
genes, whereas isolates assigned to clusters V1, V2, V3,
V5, V6 and V7 (corresponding to CGH cluster B) lacked
1 to 12 of these genes. All cluster B isolates lacked
either one or more sortase genes that are involved in
assembly of pili [31]. Serotype 7 isolates all clustered to
V1 together with MRP-EF- serotype 2 isolates. All V1
isolates lacked regulator of virulence revS, epf and srtB
and srtC, whereas they contained srtE, srtF and two iso-
lates contained srtD, but with extensive sequence varia-
tion. Serotype 9 isolates fell apart in two different
clusters, V6 and V7. Cluster V6 lacked IgA protease,
srtF, and epf, and showed minor sequence variation in
apuA and fbps. V7 isolates lacked at least 11 putative
virulence genes, among which all sortase genes. This
indicated that V7 isolates are incapable of pilus forma-
tion, and are thereby likely to be less virulent. Taken
together, our data suggests that differences in virulence
exist within the serotype 9 population. Extensive
sequence variation in a limited number of putative viru-
lence genes (glnA, ofs, IgA protease, apuA, fbps, srtD)
was detected in isolates belonging to clusters V1, V2,
V3, V5, V6 and V7, but not in V4 isolates (Figure 2).
This suggests that V4 isolates are genetically more simi-
lar to each other and to P1/7, the array strain. V4 iso-
lates exclusively express EF, none of the isolates in
clusters V1, V2, V3, V5, V6 express EF (Table 1). In this
study we show that most isolates are unable to express
the protein since they lacked the epf gene encoding EF.
Two V5 isolates have a silent epf gene. Presence of mrp
and sly genes was less indicative for protein expression.
Isolates 3995, 3988, OV209, 15009, and 5973 contained
the suilysin gene, but did not express the protein under
in vitro conditions (Table 1). Almost all isolates tested
in this study contained the mrp gene, whereas less than
half expressed the protein under in vitro conditions
(Table 1 and Figure 2) [13].
Regions of differences and core genome of S. suis
To further explore genetic diversity between S. suis
isolates, regions of difference (RDs) were identified,
which were defined as at least three consecutive ORFs
that were absent from at least one strain. Thirty-nine
RDs that varied in size from 461 bp to 27 kbp were
identified. The largest RD (27 kbp) contained cps
genes encoding serotype specific polysaccharide cap-
sule of P1/7 (serotype 2) (Table 3). Other RDs con-
tained ABC transporters, restriction modification
systems, signal peptidases (srtE, srtF), several transpor-
ters, two-component systems and several other genes
(Table 3).
Clustering of RD distribution among isolates in a den-
drogram resulted in an identical clustering compared to
CGH clustering, indicating that RDs mainly determine
the differences between isolates as detected by CGH
(Figure 3). Within cluster A, subclusters could not be
discriminated based on the absence/presence of specific
RDs, since most RDs were universally present within
cluster A isolates. Distribution of RDs among cluster B
was more heterogeneous. Three isolates from cluster B3
(22083R1, 8186 and OV640) were responsible for a good
deal of diversity: 9 RDs representing 45 genes were only
absent in one or more of these isolates; whereas in total
at least 29 RDs are missing from these isolates. Thus,
these isolates are atypical within our selection of iso-
lates. Serotype 7 and 9 isolates (in clusters B2 and B5)
also lacked considerable numbers of RDs. For some RDs
(RD1, RD6, RD17), GC content differed considerably
from overall GC content of the genome (41%), indicat-
ing these RDs might have been acquired from other spe-
cies by horizontal gene transfer, since foreign DNA can
often be recognized by its variation from the majority of
the genome in base composition or codon preference.
The gene content of RDs shows that these regions con-
tain specific beneficial traits like RM systems, ABC
transporters, or two-component systems, making it
attractive regions to acquire.
A core genome for S. suis was defined by selecting
genes that were present in all S. suis isolates tested. The
resulting core genome of S. suis consisted of 1492 genes
(76%) out of 1960 genes present on our array. Of those
1492 genes, 26 genes represent pseudogenes in P1/7.
Composition of the core genome of S. suis was studied
using the classification in clusters of orthologous groups
of proteins (COG). Figure 4 displays the relative repre-
sentation of each COG category in both P1/7 as well as
in the core genome. Most COG categories were equally
represented in both genomes. However, COG categories
J (translation, ribosomal structure and biogenesis), E
(amino acid transport and metabolism) and F (nucleo-
tide transport and metabolism) were found to be overre-
presented in the core genome. In conclusion, all isolates
in our study share 1492 genes. The overrepresentation
of the structural gene categories J, E, and F suggest this
core genome suffices for growth, division and survival,
whereas additional, beneficial traits are mainly encoded
by RDs.
Discussion
Comparative genome hybridization (CGH) was used to
study genetic heterogeneity among a collection of 55 S.
suis isolates. S. suis isolates were assigned to two clus-
ters (A and B).
CGH data was compared with MLST and pulse field
gel electrophoresis (PFGE) [6] and amplified fragment
de Greeff et al. BMC Microbiology 2011, 11:161
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Table 3 Regions of difference (RDs) identified in relation to P1/7
RD# Range in P1/7* Size
(bp)*
Present in
n/55 strains
(parts present
in n/55)
%GC$ Predicted Function*
RD01 SSU0101 - SSU0111 7.537 23 (49) 34.1 Integrase, replication initiation factor, hypothetical proteins
RD02 SSU0178 - SSU0182 5.501 47 40.8 PTS IIB, transketolase
RD03 SSU0198 - SSU0209 14.234 37 (13) 33.7 PTS IIABC transporter, glucosamine-6-phosphate isomerase, pseudogene
RD04 SSU0300 - SSU0305 5.455 36 (17) 43.0 Dehydrogenase, flavin oxidoreductase, transcription regulator lipase
RD05 SSU0346 - SSU0350 7.680 29 38.8 merR, hypothetical proteins
RD06 SSU0413 - SSU0418 8.624 29 (14) 33.6 Hypothetical proteins
RD07 SSU0423 - SSU0428 8.383 30 (11) 39.3 Signal peptidase, srtF
RD08 SSU0449 - SSU0453 2.475 52 36.0 Signal peptidase, srtE
RD09 SSU0519 - SSU0556 27.705 30 (6) 35.6 cps-genes, transposases
RD10 SSU0592 - SSU0600 8.410 52 36.7 Hypothetical proteins, D-alanine transport
RD11 SSU0640 - SSU0642 5.514 42 42.5 Type III RM
RD12 SSU0651 - SSU0655 7.674 34 (5) 38.8 Type I RM
RD13 SSU0661 - SSU0670 10.283 50 40.1 PTS IIABC, formate acetyltransferase, fructose-6-phaphate aldolase, glycerol
dehydrogenase
RD14 SSU0673 - SSU0679 8.872 45 42.1 Piryidine nucleotide-disulphide oxidoreductase, DNA-binding protein, glycerol kinase,
alpha-glycreophophate oxidase, glycerol uptake facilitator, dioxygenase
RD15 SSU0684 - SSU0693 7.868 35 38.6 Phosphatase, phosphomethylpyrimidine kinase, hydroxyethylthiazole kinase, thiamine-
phosphate pyrophosphorylase, uridine phosphorylase, cobalt transport protein, ABC
transporter
RD16 SSU0804 - SSU0815 11.036 20 30.6 Plasmid replication protein, hypothetical proteins
RD17 SSU0833 - SSU0835 2.386 31 34.1 Lantibiotic immunity
RD18 SSU0850 - SSU0852 2.345 50 40.9 Pyridine nucleotide-disulphide oxidoreductase, hypothetical proteins
RD19 SSU0902 - SSU0904 2.169 52 36.4 Hypothetical proteins
RD20 SSU0963 - SSU0968 2.769 54 43.2 Acetyltransferase, transposases
RD21 SSU0998 - SSU1008 13.688 54 42.3 Glycosyl hydrolase, UDP-N-acetylglucosamine 1-carboxyvinyltransferase, 2-deoxy-D-
gluconate 3-dehydrogenase, mannonate dehydratase, urinate isomerase, 2-dehydro-3-
deoxy-6-phosphogalactonate aldolase, beta-glucuronidase, carbohydrate kinase, sugar
transporter
RD22 SSU1047 - SSU1066 17.452 52 40.1 Hyaluronidase, PTS IIABCD, aldolase, kinase, sugar-phosphate isomerase, gluconate 5-
dehydrogenase, transposase
RD23 SSU1169 - SSU1172 4.850 53 (1) 42.6 ABC transporter
RD24 SSU1271 - SSU1274 6.695 36 (1) 35.8 Type I RM
RD25 SSU1285 - SSU1287 805 43 41.7 Hypothetical proteins
RD26 SSU1308 - SSU1310 4.130 52 36.7 PTS IIABC
RD27 SSU1330 - SSU1347 10.041 28 37.1 Phage proteins, hypothetical proteins
RD28 SSU1369 - SSU1374 7.733 53 38.8 Sucrose phosphorylase, ABC transporter
RD29 SSU1402 - SSU1407 5.018 29 (24) 41.2 Bacitracin export, transposase
RD30 SSU1470 - SSU1476 10.163 52 35.4 Two-component regulatory system, serum opacity factor
RD31 SSU1588 - SSU1592 7.771 52 40.9 Type I RM, integrase
RD32 SSU1702 - SSU1715 23.640 45 43.4 Two-component regulatory system, tranpsoase, glucosaminidase, hypothetical proteins,
alpha-1,2,-mannosidase, eno-beta-N-acetylglucusaminidase
RD33 SSU1722 - SSU1727 4.924 30 38.3 Acetyltransferase, hypothetical proteins, PTS IIBC
RD34 SSU1763 - SSU1768 6.153 29 47.1 Nicotinamide mononucleotide transporter, transcriptional regulator, hypothetical
proteins
RD35 SSU1855 - SSU1862 8.479 52 39.9 PTS IIABC, hypothetical proteins, beta-glucosidase, 6-phospho-beta-glucosidase
RD36 SSU1872 - SSU1875 1.918 36 35.4 RevS, CAAX amino terminal protease
RD37 SSU1881 - SSU1890 13.184 36 38.5 srtB, C, D
RD38 SSU1927 - SSU1931 8.444 44 41.6 b-glucosidase, two-compent regulatory system
RD39 SSU1942 - SSU1944 461 42 40.5 mutT/NUDIX hydrolase
# Region of difference is defined as regions of at least 3 ORFs that are absent from at least 1/55 S. suis strains tested.
* Naming, size and function prediction is based on genome sequence of P1/7 [7]
$ GC-percentage of P1/7 genome is 41%
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length polymorphism (AFLP)[25]. In general there was a
lot of congruence between typing methods. The discri-
minatory power of CGH is larger than that of MLST
analysis, since isolates that belong to MLST CC1 can be
divided into subclusters using CGH. Moreover,
Vietnamese isolates that belong to different pulse field
types, were assigned to the same CGH subcluster [6].
This could be explained by genomic inversions and sub-
stitutions, that were observed in the genome of the Viet-
namese reference strain BM407 in comparison to P1/7
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Figure 3 Dendrogram based on the presence/absence of regions of difference (RD) among S. suis isolates. RDs were defined as at least
three consecutive ORFs that were absent from at least 1 strain. Naming of clusters is corresponding to the CGH clustering.
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[7]. These changes can be discriminated by PFGE, but
not by CGH.
To correlate virulence of isolates to CGH results, viru-
lence of serotype 1 and serotype 9 isolates was deter-
mined in an experimental infection. For serotype 1, our
animal experiment showed that in contrast to the field
isolates, the reference strain was not highly virulent.
Since serotype 9 only induced clinical symptoms at very
high doses, we concluded that serotype 9 isolates were
avirulent under experimental conditions. This was con-
firmed by other studies [32,33]. To correlate virulence
to CGH data, distribution of 25 putative virulence genes
among S. suis isolates was studied. Each CGH cluster
was shown to be associated with a specific profile of
putative virulence genes. Cluster A isolates contained all
25 putative virulence genes. Cluster B isolates on the
contrary lacked up to 12 putative virulence genes
among which one or more of sortase genes (srtBCD,
srtE, srtF) that are involved in assembly of pili [31,34].
In agreement with data presented here, Takamatsu et al.
showed that CC1 isolates contained all srt genes,
whereas CC29 isolates lacked srtBCD genes [34]. How-
ever, none of our serotype 9 isolates contained the
srtBCD gene cluster, whereas this cluster was detected
in a Japanese serotype 9 isolate [34]. This could imply
geographical variation. Moreover, the revs gene is absent
from all cluster B isolates, with the exception of cluster
B5 isolates. This regulator influences expression of puta-
tive virulence factors [35]. Therefore, lack of revs might
affect virulence of isolates. The IgA1 protease gene was
found to be absent in all serotype 9 isolates, and dis-
played extensive sequence variation in serotype 7 iso-
lates. All serotype 2 isolates including the avirulent
isolates contained the IgA1 protease gene. Zhang et al.
showed that most pathogenic serotype 2 isolates con-
tained the IgA1 protease gene, whereas the gene was
sparsely found in non-invasive serotype 2 isolates [36].
In the latter study mainly isolates obtained in China
?
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Figure 4 Representation of COG categories among the core genome. Relative representation of COG categories in the whole genome
(hatched bars) compared to the core genome (black bars) of S. suis strain P1/7. Representation is calculated as the percentage of genes per
COG category compared to the total number of genes in the genome. COG categories: J translation, ribosomal structure and biogenesis; K
transcription; L replication, recombination and repair; D cell cycle control, cell division, chromosome partitioning; V defense mechanisms; O
posttranslational modification, protein turnover, chaperones; M cell wall/membrane/envelope biogenesis; N cell motility; U intracellular trafficking,
secretion, and vesicular transport; T signal transduction mechanisms; C energy production and conversion; P inorganic ion transport and
metabolism; G carbohydrate transport and metabolism; E amino acid transport and metabolism; F nucleotide transport and metabolism; H
coenzyme transport and metabolism; I lipid transport and metabolism; Q secondary metabolites biosynthesis, transport and catabolism; R general
function prediction only; S function unknown; ‘other’ no COG category attached.
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were used. Sequence variation among isolates belonging
to cluster B was observed for other putative virulence
genes as well, like ofs, glnA, fbps and apuA. The ofs gene
was highly conserved among virulent serotype 1 and 2
isolates but showed extensive sequence diversity in
avirulent serotype 2 and serotype 7 isolates, as was also
described by Takamatsu et al [15]. Interestingly, at least
two of the ofs positive serotype 7 strains do not express
OFS in vitro, as shown in the serum opacification assay
[37]. This suggests the presence of silent ofs genes. A
silent epf gene was present in isolates in cluster B3. Two
of the B3 isolates (22083R1 and 8186) expressed the
enlarged version of MRP, but none of the probes used
for the CGH hybridized to the mrp gene, suggesting
extensive sequence variation exists between different
serotype 9 isolates. The presence of a mrp gene in the
two isolates was confirmed by PCR analysis (data not
shown). Serotype 9 isolates were distributed among 2
virulence clusters, V6 and V7 that differed considerably
in their distribution of putative virulence genes. This
suggests differences in virulence exist among serotype 9
isolates that were not identified in our experimental
infection model.
Avirulent MRP-EF- serotype 2 isolates clustered
together with serotype 7 isolates both by CGH as well
as by MLST. Such a clustering is in agreement with pre-
vious studies [24,25]. The clustering strongly suggests
similarity in genetic background between the isolates
and could suggest that the avirulent serotype 2 isolates
originated from serotype 7 isolates after the exchange of
the capsular genes. Capsular exchange has been
described for other streptococci like GBS [38] and Strep-
tococcus pneumonia [39]. In this study 39 regions of dif-
ferences (RDs) were identified, that might contribute to
virulence or survival in the host based on the predicted
functions of the genes associated with the various RDs.
For example 3 RDs encode two-component regulatory
systems and 5 RDs encode putative virulence genes. In
addition, 6 phosphotransferase systems, and 4 ABC
transporters were identified. Since the GC content of
some RDs differed considerably compared to the whole
genome of S. suis, these RDs could have originated from
horizontal gene transfer. This suggestion can be sup-
ported by the finding that many RDs contained transpo-
sases, integrases or phage proteins which are all
involved in gene transfer.
A core genome for S. suis was defined that contained
78% of P1/7 ORFs. This percentage is in the same order
of magnitude as for other streptococcal core genomes.
A small percentage (2.4%) of the core genome is repre-
sented by pseudogenes in P1/7. Since single nucleotide
differences cannot be detected using CGH, additional
putative pseudogenes present in other isolates will not
be identified. This could lead to a small overestimation
of the core genome. In P1/7 COG category G, carbohy-
drate transport and metabolism, is overrepresented
compared to the core genome. This could reflect genes
that are not essential to S. suis, but make S. suis strains
carrying these gene(s) more versatile in their carbon
source usage. Recent publications suggest carbon source
usage may be an important virulence trait for strepto-
cocci [40], which implies the more versatile S. suis iso-
lates could benefit in pathogenesis. Since the core
genome includes genes that are shared by all isolates
included in our study, representing virulent as well as
avirulent isolates, it is not very likely the core genome
alone is sufficient for virulence. This is confirmed by the
finding of several genes putatively involved in virulence
in the RD regions of P1/7 that probably attribute to
virulence or survival in the host of P1/7. However, since
all isolates, including avirulent ones like T15, 12 and 16
[13,21], can colonize porcine tonsils, the core genome
might be sufficient for colonization.
Conclusions
In conclusion, we show that CGH is a valuable method.
Not only can it be used for genotyping of S. suis isolates,
but CGH also gives information on phylogeny of iso-
lates, and can be used to look for specific gene content,
like virulence genes, or sequence variation among iso-
lates. At present a disadvantage of CGH using the cur-
rent microarray is the one way character of the
technology; only distribution of genes present in P1/7
can be studied using the current microarray. Recently,
several S. suis isolates have been sequenced adding new
information to the S. suis pangenome. The Chinese
human isolates were shown to contain an additional
putative pathogenicity island (PI) of 89 kb compared to
P1/7 [41], whereas the Vietnamese strain BM407 con-
tained another additional PI compared to P1/7 [7]. Both
PI’s were shown to contain integrative and conjugative
elements (ICE) not present in P1/7. The current micro-
array will have to be extended with genome sequences
of other S. suis isolates to be a better representation of
the S. suis pangenome.
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